Immunostimulatory properties of mistletoe extracts and their application in oncology
For a long time cancer immunotherapy was overshadowed by chemotherapy and radiotherapy. Recently, "Science", one of the world's top scientific journals, named the stimulation of the body's own immune system to fight cancer cells as the "breakthrough of the year". In Germany, Switzerland and Austria, extracts derived from mistletoe (Viscum album L.) such as Iscador, Abnobaviscum, Helixor, Iscar, Iscucin and Isorel have been used in oncology for many years. These extracts have immunomodulating and immunostimulating properties, as demonstrated by experimental studies as well as in clinical trials. The aim of our paper is to present immunological disorders associated with cancer, which can be counteracted by treatment with extracts derived from mistletoe. Although these drugs cannot replace conventional cancer treatment, they may improve the patient's quality and length of life.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
Postepy higieny i medycyny doswiadczalnej (Online) - 68(2014) vom: 23. Okt., Seite 1216-24 |
Sprache: |
Polnisch |
---|
Weiterer Titel: |
Immunostymulujące właściwości preparatów pozyskiwanych z jemioły i ich zastosowanie w onkologii |
---|
Beteiligte Personen: |
Wrotek, Sylwia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antineoplastic Agents, Phytogenic |
---|
Anmerkungen: |
Date Completed 17.08.2015 Date Revised 17.03.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.5604/17322693.1126850 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM243385072 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM243385072 | ||
003 | DE-627 | ||
005 | 20231224132422.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||pol c | ||
024 | 7 | |a 10.5604/17322693.1126850 |2 doi | |
028 | 5 | 2 | |a pubmed24n0811.xml |
035 | |a (DE-627)NLM243385072 | ||
035 | |a (NLM)25380204 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a pol | ||
100 | 1 | |a Wrotek, Sylwia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immunostimulatory properties of mistletoe extracts and their application in oncology |
246 | 3 | 3 | |a Immunostymulujące właściwości preparatów pozyskiwanych z jemioły i ich zastosowanie w onkologii |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.08.2015 | ||
500 | |a Date Revised 17.03.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a For a long time cancer immunotherapy was overshadowed by chemotherapy and radiotherapy. Recently, "Science", one of the world's top scientific journals, named the stimulation of the body's own immune system to fight cancer cells as the "breakthrough of the year". In Germany, Switzerland and Austria, extracts derived from mistletoe (Viscum album L.) such as Iscador, Abnobaviscum, Helixor, Iscar, Iscucin and Isorel have been used in oncology for many years. These extracts have immunomodulating and immunostimulating properties, as demonstrated by experimental studies as well as in clinical trials. The aim of our paper is to present immunological disorders associated with cancer, which can be counteracted by treatment with extracts derived from mistletoe. Although these drugs cannot replace conventional cancer treatment, they may improve the patient's quality and length of life | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Antineoplastic Agents, Phytogenic |2 NLM | |
650 | 7 | |a Immunologic Factors |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
650 | 7 | |a Plant Proteins |2 NLM | |
650 | 7 | |a viscum album peptide |2 NLM | |
650 | 7 | |a BK9092J5MP |2 NLM | |
700 | 1 | |a Skawiński, Robert |e verfasserin |4 aut | |
700 | 1 | |a Kozak, Wiesław |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Postepy higieny i medycyny doswiadczalnej (Online) |d 2004 |g 68(2014) vom: 23. Okt., Seite 1216-24 |w (DE-627)NLM147657105 |x 1732-2693 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2014 |g day:23 |g month:10 |g pages:1216-24 |
856 | 4 | 0 | |u http://dx.doi.org/10.5604/17322693.1126850 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 68 |j 2014 |b 23 |c 10 |h 1216-24 |